These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 3987769)
21. Lung delivery of salbutamol given by breath activated pressurized aerosol and dry powder inhaler devices. Lipworth BJ; Clark DJ Pulm Pharmacol Ther; 1997 Aug; 10(4):211-4. PubMed ID: 9695144 [TBL] [Abstract][Full Text] [Related]
22. Efficacy and tolerability of salmeterol/fluticasone propionate versus montelukast in childhood asthma: A prospective, randomized, double-blind, double-dummy, parallel-group study. Maspero J; Guerra F; Cuevas F; Gutierrez JP; Soto-Ramos M; Anderton S; Mechali D; Chan R; Pedersen S Clin Ther; 2008 Aug; 30(8):1492-504. PubMed ID: 18803991 [TBL] [Abstract][Full Text] [Related]
23. The effect of powder aerosol compared to pressurized aerosol. Svedmyr N; Löfdahl CG; Svedmyr K Eur J Respir Dis Suppl; 1982; 119():81-8. PubMed ID: 6954092 [TBL] [Abstract][Full Text] [Related]
24. Comparison of a single dose of aerosol salbutamol and fenoterol/ipratropium on bronchial asthmatic patients. Filiz A; Ekinci E; Dikensoy O; Bulgur D; Oz M Del Med J; 1994 Oct; 66(10):549-52. PubMed ID: 7958119 [TBL] [Abstract][Full Text] [Related]
25. Treatment of acute severe asthma with inhaled albuterol delivered via jet nebulizer, metered dose inhaler with spacer, or dry powder. Raimondi AC; Schottlender J; Lombardi D; Molfino NA Chest; 1997 Jul; 112(1):24-8. PubMed ID: 9228352 [TBL] [Abstract][Full Text] [Related]
26. Time course and duration of bronchodilatation with formoterol dry powder in patients with stable asthma. Wallin A; Sandström T; Rosenhall L; Melander B Thorax; 1993 Jun; 48(6):611-4. PubMed ID: 8346490 [TBL] [Abstract][Full Text] [Related]
27. Efficacy, tolerability, and effect on asthma-related quality of life of formoterol bid via multidose dry powder inhaler and albuterol QID via metered dose inhaler in patients with persistent asthma: a multicenter, randomized, double-blind, double-dummy, placebo-controlled, parallel-group study. Busse W; Levine B; Andriano K; Lavecchia C; Yegen U Clin Ther; 2004 Oct; 26(10):1587-98. PubMed ID: 15598475 [TBL] [Abstract][Full Text] [Related]
28. Effect of intravenous injection of salbutamol in asthma. May CS; Paterson JW; Spiro SG; Johnson AJ Br J Clin Pharmacol; 1975 Dec; 2(6):495-501. PubMed ID: 1234013 [TBL] [Abstract][Full Text] [Related]
29. Easyhaler, a novel multiple dose powder inhaler: clinically equivalent to salbutamol metered dose inhaler and easier to use. Nieminen MM; Vidgren M; Laurikainen K; Järvinen M; Liippo K; Tammivaara R; Silvasti M Respiration; 1994; 61(1):37-41. PubMed ID: 8177971 [TBL] [Abstract][Full Text] [Related]
30. A new inhalation technique for freon aerosols. Terbutaline aerosol with a tube extension in a 2-day cross-over comparison with salbutamol aerosol. Eriksson NE; Haglind K; Hidinger KG Allergy; 1980 Oct; 35(7):617-22. PubMed ID: 7468948 [TBL] [Abstract][Full Text] [Related]
31. Salbutamol: tablets, inhalational powder, or nebuliser? Grimwood K; Johnson-Barrett JJ; Taylor B Br Med J (Clin Res Ed); 1981 Jan; 282(6258):105-6. PubMed ID: 6779890 [TBL] [Abstract][Full Text] [Related]
32. Inhaled salmeterol and salbutamol in asthmatic patients. An evaluation of asthma symptoms and the possible development of tachyphylaxis. Ullman A; Hedner J; Svedmyr N Am Rev Respir Dis; 1990 Sep; 142(3):571-5. PubMed ID: 1975162 [TBL] [Abstract][Full Text] [Related]
33. Effect of long-term salmeterol therapy compared with as-needed albuterol use on airway hyperresponsiveness. Rosenthal RR; Busse WW; Kemp JP; Baker JW; Kalberg C; Emmett A; Rickard KA Chest; 1999 Sep; 116(3):595-602. PubMed ID: 10492259 [TBL] [Abstract][Full Text] [Related]
34. Comparison of salbutamol dry powder aerosol with pressurised aerosol. Chhabra SK Indian J Chest Dis Allied Sci; 1993; 35(4):163-6. PubMed ID: 8039816 [TBL] [Abstract][Full Text] [Related]
35. Comparison of bronchodilating effects of two salbutamol dry powder inhalers in asthmatic patients. Laurikainen K; Silvasti M; Calderon P; Lins R; Rosillon D Arzneimittelforschung; 1997 Jan; 47(1):44-6. PubMed ID: 9037443 [TBL] [Abstract][Full Text] [Related]
36. The superiority of combination beclomethasone and salbutamol over standard dosing of salbutamol in the treatment of chronic asthma. Haahtela T; Alanko K; Muittari A; Lahdensuo A; Sahlström K; Vilkka V Ann Allergy; 1989 Jan; 62(1):63-6. PubMed ID: 2912326 [TBL] [Abstract][Full Text] [Related]
37. Comparison of oral bambuterol and inhaled salmeterol in patients with symptomatic asthma and using inhaled corticosteroids. Crompton GK; Ayres JG; Basran G; Schiraldi G; Brusasco V; Eivindson A; Jamieson AH; Olsson H Am J Respir Crit Care Med; 1999 Mar; 159(3):824-8. PubMed ID: 10051257 [TBL] [Abstract][Full Text] [Related]
38. A Randomized Controlled Trial of 2 Inhalation Methods When Using a Pressurized Metered Dose Inhaler With Valved Holding Chamber. Stephen D; Vatsa M; Lodha R; Kabra SK Respir Care; 2015 Dec; 60(12):1743-8. PubMed ID: 26081179 [TBL] [Abstract][Full Text] [Related]
39. A comparison of rimiterol and salbutamol by inhalation at high and low dose in asthmatic patients. Muittari A Respiration; 1978; 35(3):165-72. PubMed ID: 25466 [TBL] [Abstract][Full Text] [Related]
40. The efficacy, as modified by the circadian rhythm of salbutamol administered by different routes. Lahdensuo A; Alanko K Scand J Respir Dis; 1976; 57(5):231-8. PubMed ID: 792993 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]